Dr. Katharina Warncke

Oberärztin der Kinderendokrinologie und der Kinderdiabetologie, Stellvertretende Lehrbeauftragte der Klinik für Kinder- und Jugendmedizin, Endokrinologie-Kinder und Kinder- und Jugendmedizin (alle Fachbereiche)

München Klinik Schwabing

Kontakt

Tel: (089) 3068 2632 Fax: (089) 3068 3849

Nachricht an Dr. Katharina Warncke

Adresse

München Klinik Schwabing Kölner Platz 1, 80804 München

  • Personalien >>

Fachärztin für Kinder- und Jugendmedizin
Schwerpunkt Kinderendokrinologie/-diabetologie
Diabetologin DDG
Diabetologin BLAEK
Fachkunde genetische Beratung

Zusatzbezeichnung
Diabetologie (BLAEK), Diabetologin DDG

Schwerpunktbezeichnung
Kinderendokrinologie und -diabetologie

Mitgliedschaften
Deutsche Gesellschaft für Kinder- und Jugendmedizin
Deutsche Gesellschaft für Kinder- und Jugendendokrinologie und -diabetologie
Deutsche Diabetesgesellschaft
European Society for Pediatric Endocrinology  

Beruflicher Werdegang
1997-2004
Studium der Humanmedizin an der Ludwig Maximilians Universität München
seit 2004
Klinik für Kinder- und Jugendmedizin des Klinikums Rechts der Isar der TU München, Kinderklinik Schwabing
2009
Facharztanerkennung Kinder- und Jugendmedizin
2010
Diabetologin DDG
2011
Zusatzbezeichnung Diabetologie (Bayer. Landesärztekammer)
seit 2013
Teilnahme am Rufbereitschaftsdienst der Kinderklinik
2014
Schwerpunktanerkennung pädiatrische Endokrinologie/Diabetologie

 

Akademisches Curriculum
2005

Promotion: Charakterisierung der humoralen Autoimmunität im Verlauf der präklinischen Phase des Typ 1 Diabetes

Auszeichnung
2006
Gerhard Mohnike Förderpreis der Deutschen Diabetesgesellschaft für die Promotionsarbeit

 

Diabetes bei Kindern und Jugendlichen
neonataler Diabetes
Endokrinologische Erkrankungen:
Wachstums- und Pubertätsstörungen, Schilddrüsenerkrankungen, Erkrankungen der Nebennieren und der Hypophyse

Publikationsverzeichnis

Erstautorenschaften

  • Warncke K, Lickert R, Eitel S, Gloning KP, Bonifacio E, Sedlmeier EM, Becker P, Knoop J, Beyerlein A, Ziegler AG.Thymus Growth and Fetal Immune Responses in Diabetic Pregnancies.HormMetab Res. 2017 Nov;49(11):892-898.
  • Warncke K, Konrad K, Kohne E, Hammer E, Ohlenschläger U, Herrlinger S, Jaeger A, Holl RW.Diabetes in patients with ß-thalassemia or other hemoglobinopathies – analysis from the DPV Database. Klin Padiatr. 2016 Nov;228(6-07):307-312.
  • Warncke K, Falco F, Rabl W, Engelsberger I, Saier J, Flores-Rodriguez D, Burdach S, Bonfig W. Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center. J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1187-1194. doi: 10.1515/jpem-2016-0103.
  • Warncke K, Liptay S, Fröhlich-Reiterer E, Scheuing N, Schebek M, Wolf J, Rohrer TR, Meissner T, Holl RW for the German/Austrian Diabetes Prospective documentation ascular risk factors in children, adolescents and young adults with type 1 diabetes complicated by celiac disease: Results from the DPV initiative. Pediatr Diabetes 2016; 17(3):191-8. doi: 10.1111/pedi.12261. Epub 2015 Feb 12.
  • Warncke K, Krasmann M, Puff R, Dunstheimer D, Ziegler AG, Beyerlein A. Does Diabetes Appear in Distinct Phenotypes in Young People? Results of the Diabetes Mellitus Incidence Cohort Registry (DiMelli). PLoS One. 2013 Sep 4;8(9):e74339. doi: 10.1371/journal.pone.0074339.
  • Warncke K, Fröhlich-Reiterer EE, Thon A, Hofer SE, Wiemann D, Holl RW; DPV Initiative of the German Working Group for Pediatric Diabetology; German BMBF Competence Network for Diabetes Mellitus. Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database.Diabetes Care. 2010 Sep;33(9):2010-2.



Co-Autorenschaften

  • Leszinski GS,Warncke K,Hoefele J,Wagner M.A case report and review of the literature indicate that HMGA2 should be added as a disease gene for Silver-Russell syndrome.Gene.2018 Jul 15;663:110-114.
  • Köhler M, Beyerlein A, Vehik K, Greven S, Umlauf N, Lernmark Å, Hagopian WA, Rewers M, She JX, Toppari J, Akolkar B, Krischer JP, Bonifacio E, Ziegler AG;TEDDY Study group.Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study. Acta Diabetol. 2017.54(11):1009-1017
  • Lundgren M, Steed LJ, Tamura R, Jonsdottir B, Gesualdo P, Crouch C, Sjöberg M, Hansson G, Hagopian WA, Ziegler AG, Rewers MJ, Lernmark Å, Toppari J, She JX, Akolkar B, Krischer JP, Haller MJ, Elding Larsson H;TEDDY Study Group. Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity. BMC Pediatr. 2017;17(1):127. doi: 10.1186/s12887-017-0884-y.
  • Haghighi M, Johnson SB, Qian X, Lynch KF, Vehik K, Huang S;TEDDY Study GroupA Comparison of Rule-based Analysis with Regression Methods in Understanding the Risk Factors for Study Withdrawal in a Pediatric Study. Sci Rep. 2016;6:30828.
  • Raab J, Haupt F, Scholz M, Matzke C,Warncke K,Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG; Fr1da Study Group. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016 May 18;6(5):e011144. doi: 10.1136/bmjopen-2016-011144.
  • Törn C, Liu X, Hagopian W, Lernmark Å, Simell O, Rewers M, Ziegler AG, Schatz D, Akolkar B, Onengut-Gumuscu S, Chen WM, Toppari J, Mykkänen J, Ilonen J, Rich SS, She JX, Sharma A, Steck A, Krischer J;TEDDY Study Group. Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Sci Rep. 2016;6:27887.
  • Lernmark B, Lynch K, Baxter J, Roth R, Simell T, Smith L, Swartling U, Johnson SB;Teddy Study Group. Participant Experiences in the Environmental Determinants of Diabetes in the Young Study: Common Reasons for Withdrawing. J Diabetes Res. 2016;2016:2720650. doi: 10.1155/2016/2720650. Epub 2015 Nov 22.
  • Uusitalo U, Liu X, Yang J, Aronsson CA, Hummel S, Butterworth M, Lernmark Å, Rewers M, Hagopian W, She JX, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer J, Norris JM, Virtanen SM;TEDDY Study Group.Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr. 2016;170(1):20-8. doi: 10.1001/jamapediatrics.2015.2757.
  • Andrén Aronsson C, Lee HS, Koletzko S, Uusitalo U, Yang J, Virtanen SM, Liu E, Lernmark Å, Norris JM, Agardh D;TEDDY Study Group. Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort. Clin Gastroenterol Hepatol. 2016;14(3):403-409.e3. doi: 10.1016/j.cgh.2015.09.030. Epub 2015
  • Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, Theil A, Eugster A, Puff R, Peplow C, Buettner F, Lange K, Hasford J, Achenbach P;Pre-POINT Study Group. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial. JAMA. 2015;313(15):1541-9. doi: 10.1001/jama.2015.2928.
  • Lönnrot M, Lynch K, Larsson HE, Lernmark Å, Rewers M, Hagopian W, She JX, Simell O, Ziegler AG, Akolkar B, Krischer J, Hyöty H;TEDDY Study Group. A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY. BMC Pediatr. 2015;15:24. doi: 10.1186/s12887-015-0333-8.
  • Agardh D, Lee HS, Kurppa K, Simell V, Aronsson CA, Jörneus O, Hummel M, Liu E, Koletzko S;TEDDY Study Group. Clinical features of celiac disease: a prospective birth cohort. Pediatrics 2015; 135(4):627-34. doi: 10.1542/peds.2014-3675. Epub 2015 Mar 2.
  • Beyerlein A, Krasmann M, Thiering E, Kusian D, Markevych I, D’Orlando O,Warncke K, Jochner S, Heinrich J, Ziegler AG. DExposure to ambient air pollution and early manifestation of type 1 diabetes: results from an observational cohort study. Research Letter. Epidemiology. 2015 May;26(3):e31-2. doi: 10.1097
  • Steck AK, Vehik K, Bonifacio E, Lernmark A, Ziegler AG, Hagopian WA, She J, Simell O, Akolkar B, Krischer J, Schatz D, Rewers MJ;TEDDY Study Group. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Diabetes Care. 2015;38(5):808-13. doi: 10.2337/dc14-2426. Epub 2015 Feb 9.
  • Aronsson CA, Lee HS, Liu E, Uusitalo U, Hummel S, Yang J, Hummel M, Rewers M, She JX, Simell O, Toppari J, Ziegler AG, Krischer J, Virtanen SM, Norris JM, Agardh D;TEDDY STUDY GROUP.Age at gluten introduction and risk of celiac disease. Pediatrics 2015; 135(2):239-45. doi: 10.1542/peds.2014-1787. Epub 2015 Jan 19.
  • Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, León-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian W, She JX, Krischer JP, Akolkar B, Schatz DA, Atkinson MA, Triplett EW;TEDDY Study Group. Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 2015; 38(2):329-32. doi: 10.2337/dc14-0850. Epub 2014 Dec 17.
  • Törn C, Hadley D, Lee HS, Hagopian W, Lernmark Å, Simell O, Rewers M, Ziegler A, Schatz D, Akolkar B, Onengut-Gumuscu S, Chen WM, Toppari J, Mykkänen J, Ilonen J, Rich SS, She JX, Steck AK, Krischer J;TEDDY Study Group. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study. Diabetes 2015; 64(5):1818-29.
  • Steinborn M, Friedmann M, Hahn H, Hapfelmeier A, Macdonald E,Warncke K, Saleh A. Normal Values for Transbulbar Sonography and Magnetic Resonance Imaging of the Optic Nerve Sheath Diameter (ONSD) in Children and Adolescents. Ultraschall Med. 2015 Feb;36(1):54-8. doi: 10.1055/s-0034-1385012. Epub 2014 Aug 20
  • Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, Eisenbarth GS, Bingley PJ, Bonifacio E, Simell V, Agardh D;TEDDY Study Group. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371(1):42-9. doi: 10.1056/NEJMoa131397
  • Yang J, Lernmark Å, Uusitalo UM, Lynch KF, Veijola R, Winkler C, Larsson HE, Rewers M, She JX, Ziegler AG, Simell OG, Hagopian WA, Akolkar B, Krischer JP, Vehik K;TEDDY Study Group. Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes. Int J Obes (Lond). 2014; 38(12):1491-6. doi: 10.1038/ijo.2014.55.
  • Raab J, Giannopoulou E, Schneider S,Warncke K, Krasmann M, Winkler C, Ziegler AG. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia 2014 ;57(5):902-8
  • Lee HS, Burkhardt BR, McLeod W, Smith S, Eberhard C, Lynch K, Hadley D, Rewers M, Simell O, She JX, Hagopian B, Lernmark A, Akolkar B, Ziegler AG, Krischer JP;TEDDY study group. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study.Diabetes Metab Res Rev. 2014;30(5):424-34. doi: 10.1002/dmrr.2510.
  • Elding Larsson H, Vehik K, Gesualdo P, Akolkar B, Hagopian W, Krischer J, Lernmark Å, Rewers M, Simell O, She JX, Ziegler A, Haller MJ;TEDDY Study Group.Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.Pediatr Diabetes. 2014; 15(2):118-26. doi: 10.1111/pedi.12066.
  • Aronsson CA, Vehik K, Yang J, Uusitalo U, Hay K, Joslowski G, Riikonen A, Ballard L, Virtanen SM, Norris JM;TEDDY Study Group.Use of dietary supplements in pregnant women in relation to sociodemographic factors - a report from The Environmental Determinants of Diabetes in the Young (TEDDY) study. Public Health Nutr. 2013; 16(8):1390-402. doi: 10.1017/S1368980013000293.
  • Ellerbroek V,Warncke K, Köhle J, Bonfig W. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism. J Pediatr Endocrinol Metab 2013;26(11-12):1023-8
  • Bonifacio E,Warncke K, Winkler C, Wallner M, Ziegler AG. Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes. 2011; 60(12):3300-6
  • Achenbach P,Warncke K, Reiter J, Williams AJ, Ziegler AG, Bingley PJ, Bonifacio E. Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives.Diabetologia 2006; 49: 2969-76.
  • Achenbach P,Warncke K, Reiter J, Naserke HE, Williams AJK, Bingley PJ, Bonifacio E, Ziegler AG. 2004.Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.Diabetes 2004; 53: 384-392. 14747289 2004 8.3



Kasuistiken und Buchbeiträge

  • Metz J,Kesper MS,Uetz B,Burdach S,Warncke K.Transient Pseudohypoaldosteronism - an Important Differential Diagnosis to Congenital Adrenal Hyperplasia].Klin Padiatr.2018 Mar 21. doi: 10.1055/a-0575-4068.
  • Warncke K, Engelsberger I. Difficult diagnosis in a 17-year-old patient.Dtsch Med Wochenschr. 2014;139(21):1097-9.
  • Warncke K, Dreßel P, Ziegler AG, Steinborn M, Bonfig W, Burdach S, Engelsberger I. Severe pre-treatment cerebral edema in newly diagnosed type 1 diabetes.A severe complication of type 1 diabetes. Horm Res Paediatr. 2014;81(4):285-8.
  • Chatenoud L,Warncke K, Ziegler AG. Clinical immunologic interventions for the treatment of type 1 diabetes.Cold Spring Harb Perspect Med. 2012;2(8).
  • Warncke K,Ziegler AG. Pathophysiologie des Typ 1 Diabetes. Erschienen „Haak/ Palitzsch: Diabetologie für die Praxis“ im Georg Thieme Verlag 2012.
  • Bonfig W, Hermanns S,Warncke K, Eder G, Engelsberger I, Burdach S, Ziegler AG, Lohse P. GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation. ISRN Pediatr. 2011;2011:676549
  • Harsunen MH,Warncke K. Primär- und Sekundärprävention des Typ 1 Diabetes. Diabetologe 2011 • 7:561–567.
  • Warncke K, Steinborn M, Burdach S, Baumeister FA.Acute encephalopathy in salmonella infection. Klin Padiatr. 2008; 220(2):88-90

Mitarbeiterverzeichnis und Stellenangebote